This is almost like a good news/bad news day for the company. The big news is having the first drug on the market to treat atrial fibrillation, which has also been treated with devices. The cancer connection still lingers with their diabetes drug questioning the amount of time spent actually tracking patients, and the FDA will continue to review additional information and studies related to Lantus. BD
Boston (DbTechNo) - The FDA (Food and Drug Administration) have just approved a drug made by Sanofi-Aventis for treating patients
with heart arrhythmias.
Arrhythmias are characterized by tan abnormal heartbeat, which can result in death if not treated properly and timely.
The drug is called Multaq, and was approved by the FDA after a 3 year delay.
It will be sold in pill form in a dose of 400-milligrams and is taken twice daily.
According to Sanofi their drug is the first on the market to treat atrial fibrillation to show reduced numbers of hospitalizations due to irregular heartbeats.
Sanofi-Aventis Heart Drug Approved by FDA : dBTechno
0 comments :
Post a Comment